China National Accord Medicines Corporation Ltd. (SHE:000028)
China · Delayed Price · Currency is CNY 25.55
+0.11 (0.43%)
Mar 26, 2026, 1:55 PM CST
SHE:000028 Revenue
In the year 2025, China National Accord Medicines Corporation had annual revenue of 73.42B CNY, down -1.29%. China National Accord Medicines Corporation had revenue of 18.29B in the quarter ending December 31, 2025, with 2.12% growth.
Revenue
73.42B
Revenue Growth
-1.29%
P/S Ratio
0.18
Revenue / Employee
1.86M
Employees
39,449
Market Cap
13.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 73.42B | -962.64M | -1.29% |
| Dec 31, 2024 | 74.38B | -1.10B | -1.46% |
| Dec 31, 2023 | 75.48B | 2.03B | 2.77% |
| Dec 31, 2022 | 73.44B | 5.09B | 7.44% |
| Dec 31, 2021 | 68.36B | 8.71B | 14.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.66B |
| China National Medicines Corporation | 52.47B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |
| Liaoning Cheng Da | 11.12B |